⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Whiterabbit.ai and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Whiterabbit.ai
↗Sunnyvale, USA
Whiterabbit.ai is a Silicon Valley-based healthcare technology company focused on improving early cancer detection through artificial intelligence. The company develops deep learning platforms that analyze medical imaging, specifically mammograms, to enhance the accuracy of breast cancer screening and reduce false positives.
Its flagship products, WRDensity and WRRisk, are designed to optimize clinical workflows and improve patient outcomes. The company collaborates with prominent medical institutions, including Stanford University and the Mallinckrodt Institute of Radiology at Washington University in St. Louis, to validate its clinical algorithms and expand its diagnostic capabilities.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Venture-backed
Investors:Celesta Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Software Product)
Modalities:AI/Software as a Medical Device
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Stanford University (Clinical research), Washington University/Mallinckrodt Institute of Radiology (Data partnership), RadNet (Diagnostic clinic network deployment), Guardant Health
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Alexander Sardina - CEO
LINKS
Website:whiterabbit.ai
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Whiterabbit.ai. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.